Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats

Fig. 2

Diagrammatic representation of the experimental design showing the study timeline and the rat pup treatment groups. Neonatal Sprague Dawley rats were reared in either room air (RA) or hyperoxia (85% O2) from postnatal days 1 to 14. On postnatal day 4, the rats received intratracheal injections of either 20 μL of normal saline (NS) or 20 μL of surfactant. On postnatal day 5, the rats reared in RA received intratracheal NS, and the rats reared in O2 received intratracheal NS or hUC-MSCs (3 × 104 or 3 × 105 cells). MSCs mesenchymal stem cells

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512